NMPA Approval

Human Erythropoietin Injection

Approval Number

国药准字J20171084

Registration Date

January 19, 2020

Previous Approval Numbers

S20171018S20171019

Drug Information

Generic Name

人促红素注射液

Trade Name

利血宝

Dosage Form

注射剂

Strength

10支/盒

Drug Type

生物制品

Registration Date

January 19, 2020

Company Address

1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan

Company Address

1040-22, Matsunoki-machi, Takayama City, Gifu, Japan

Empowering clinical research with data-driven insights and AI-powered tools.

人促红素注射液 - NMPA 批准文号 | MedPath